Navigation Links
Novis Pharmaceuticals Announces John W. Kilgour as Executive Vice-President of Sales & Marketing
Date:8/10/2008

MIAMI, Aug. 11 /PRNewswire/ -- Novis Pharmaceuticals, a leading distributor of biotherapeutic products to healthcare providers, announced today that John W. Kilgour has been named Executive Vice President of Sales and Marketing. John is a healthcare professional with thirty-five years of business and management experience in both pharmaceutical and medical/surgical supply chain distribution.

Recently retired from Cardinal Health, John held positions of increasing responsibility for more than 35 years and most recently served as Vice President of Sales in Cardinal's Pharmaceutical Supply Chain Program. Primary responsibilities included sales to Integrated Delivery Networks (IDNs) and particular emphasis on resource leadership, coaching and developing Cardinal's related sales groups. Other key positions within Cardinal Health included sales management to national and regional Group Purchasing Organizations (GPOs) as well as managing pharmaceutical and medical supply sales and marketing initiatives for the acute care and managed care business segments.

Tom Burke, President and CEO of Novis Pharmaceuticals, said, "John will be a great mentor and teacher for our employees and an even better advocate for our customers. He has established longstanding, solid relationships and has a reputation of going the extra mile for clients, employees, and especially patients. His knowledge of the industry is second to none and we consider ourselves very fortunate to have him as part of the Novis team."

"I am excited to be here," added John Kilgour. "I am very impressed with Novis' core competencies and the really exceptional people who work here. This is a talented, enthusiastic and energetic group dedicated to exceeding customer expectations while meeting important patient need. Simply stated, the 'customer relationship' and 'dedication to patient need' is paramount in all that we do."

"This is a very challenging time in our industry," he continued.
'/>"/>

SOURCE Novis Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Renovis Announces Expiration of Hart-Scott-Rodino (HSR) 30-Day Waiting Period; Merger With Evotec on Track to Close in Early May, 2008
2. Novis Pharmaceuticals Hires Lisa Lopez
3. Novis Pharmaceuticals Announces Hiring of Thomas E. Burke III as President and CEO
4. Inovis Sponsors ASC X12 Conference, Exhibits BizManager and Secure Link
5. Renovis Announces Management Changes
6. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results
7. Alseres Pharmaceuticals to Host 2008 Second Quarter Conference Call
8. Cipher Pharmaceuticals announces U.S. distribution and supply agreement with Ranbaxy for CIP-ISOTRETINOIN
9. Pacira Pharmaceuticals, Inc. Adds Experienced CFO James S. Scibetta to Leadership of the Organization
10. NUCRYST Pharmaceuticals to Release Second Quarter 2008 Financial Results on Tuesday, August 12, 2008
11. Indevus Pharmaceuticals Announces Third Quarter Fiscal 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... March 05, 2015 Afterglow®, a ... wave technology has just been rated #1 in ... A Boyfriend.” Developed by urogynecologist Dr. Ralph Zipper, ... levels of arousal by themselves and with their ... light technology to enhance a women's sensual experience ...
(Date:3/5/2015)... TULSA, OK (PRWEB) March 05, 2015 ... been to build a faster, safer, smarter commercial lifting ... the company has an increasing role in more ... lifting systems last month – Octapad System for lifting ... place concrete barriers during road construction projects. , ...
(Date:3/5/2015)... 05, 2015 ThermiHealth today announces ... for OB-GYNs and Urogynecologists. ThermiVa is a unique ... dermatological application in aesthetics and other medical specialties. ... non-invasive, in-office procedure, and patients reporting excitement about ... results without surgery. ThermiVa was developed by ThermiGyn, ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 In recognition ... to help patients, Soho Flordis International (SFI) has been ... SFI is a global natural medicine company committed to ... evidence of quality, safety, and effectiveness. For these efforts ... E. Tyler Commercial Investment in Phytomedicinal Research Award. ...
(Date:3/5/2015)... 05, 2015 Hoggan Scientific, ... ergoFET physical therapy, ergonomic force gauges, and ... ergonomics, engineering, and research applications, introduced ... available at http://www.HogganHealth.net . The new ... healthcare professionals a handgrip muscle strength testing ...
Breaking Medicine News(10 mins):Health News:Doctor’s Afterglow® Vibrator Enhances Women’s Arousal Using Light Waves, Ranks #1 In "Sex Toys That Are Better Than A Boyfriend" 2Health News:New Vacuworx Concrete Lifting Systems Aid Safer, Greener Environment As Contractors Seek LEED Incentives 2Health News:New Vacuworx Concrete Lifting Systems Aid Safer, Greener Environment As Contractors Seek LEED Incentives 3Health News:ThermiHealth Announces the Introduction of ThermiVa in North America to OB-GYNs 2Health News:ThermiHealth Announces the Introduction of ThermiVa in North America to OB-GYNs 3Health News:SFI Receives Prestigious ABC’s Tyler Award Given For Global Research Effort 2Health News:SFI Receives Prestigious ABC’s Tyler Award Given For Global Research Effort 3Health News:New Handgrip Strength Tester Receives Rave Reviews At Physical Therapy Conference 2
... WASHINGTON, Dec. 21 The new Secretary of,Veterans Affairs ... those hospitalized in VA facilities, during the,holiday season and ... be unable to be with their families during,the holidays," ... "The,good cheer and spirit of compassion during the season ...
... research suggests , FRIDAY, Dec. 21 (HealthDay News) -- Treating ... concludes a University of Pennsylvania School of Medicine study in ... , It found that providing depression care management to older ... over five years by about 50 percent. , "Depression is ...
... workflow and data connectivity for ambulatory care ... ... Wash., Dec. 21 Cardiac Science,Corporation, (Nasdaq: CSCX ), ... that it completed the,connectivity of its HeartCentrix(R) ECG informatics software ...
... Partners with Kashi, America,s Milk Processors and, Bally Total ... the ... the Participant --, SILVER SPRING, Md., Dec. 21 ... the obesity epidemic,with its biggest and best year yet, with ...
... of providing comprehensive screening and diagnostic services to under-or ... cervical cancer for treatment. Dr. Donatus U. Ekwueme of ... Promotion at the Centers for Disease Control and Prevention ... of screening a woman for breast cancer was $94, ...
... ISTA Pharmaceuticals,Inc. (Nasdaq: ISTA ), announced today ... to the U.S. Food and Drug Administration (FDA) ... for Xibrom QD,as a treatment for inflammation, pain, ... solution), Xibrom is a topical non-steroidal anti-inflammatory ...
Cached Medicine News:Health News:VA Salutes Volunteers' Spreading Holiday Cheer 2Health News:Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Greenway(R) Medical Technologies 2Health News:Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Greenway(R) Medical Technologies 3Health News:Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Greenway(R) Medical Technologies 4Health News:Discovery Health's Fifth Annual National Body Challenge Takes a Stand Against Obesity by Offering the Keys to Adopting a Healthy, Active Lifestyle 2Health News:Discovery Health's Fifth Annual National Body Challenge Takes a Stand Against Obesity by Offering the Keys to Adopting a Healthy, Active Lifestyle 3Health News:Study determines costs of breast and cervical cancer detection among low-income women 2Health News:ISTA Pharmaceuticals Submits New Drug Application for Xibrom(TM) QD (once-daily) 2
(Date:3/4/2015)... 5. März 2015 Unfors ... im Bereich diagnostische Röntgenstrahlung, stellte heute ... dem European Congress of Radiology (ECR) ... Österreich, einen neuen Strahlungsüberwachungssensor vor. ... Der RaySafe X2-Überwachungssensor ...
(Date:3/4/2015)... Holdings, Inc. (NYSE: HRC ) announced today ... to its Board of Directors.  She most recently served ... as President of Covidien,s Vascular Therapies Division from 2012 to ... 2012. Ms. Enxing Seng joined Covidien in ... she was a founding member and executive officer responsible ...
(Date:3/4/2015)...  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... Phase II proof of concept clinical study investigating ... monotherapy in the treatment of chronic pruritus in ... and clinically meaningful improvement from baseline by tradipitant ... a 100mm unit Visual Analog Scale (VAS) for ...
Breaking Medicine Technology:Unfors RaySafe, ein Unternehmen von Fluke Biomedical, stellt auf European Congress of Radiology neuen Überwachungssensor vor 2Unfors RaySafe, ein Unternehmen von Fluke Biomedical, stellt auf European Congress of Radiology neuen Überwachungssensor vor 3Hill-Rom Elects Stacy Enxing Seng to its Board of Directors 2Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 2Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 3Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 4Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 5Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 6Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 7
... The microprocessor controlled, Blanketrol ... therapy system provides effective patient ... one system! The Blanketrol II ... highest flow rates of any ...
Inquire...
Inquire...
... and accurate immunoassay for the quantification of ... fully automated Elecsys proBNP assay helps to ... NT-proBNP levels also indicate the severity of ... prognosis. In addition, NT-proBNP facilitates monitoring, allowing ...
Medicine Products: